William V Good, Earl A Palmer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBiasHumansInfant, NewbornInfant, PrematureOutcome Assessment, Health CareRecurrenceResearch Design/standardsRetinopathy of Prematurity/drug therapy
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2011 PMID: 21675899 DOI: 10.1056/NEJMc1103460
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245